Aquestive Therapeutics Inc (AQST)
2.50
-0.18
(-6.72%)
USD |
NASDAQ |
Jun 20, 16:00
2.505
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Revenue (Annual): 50.58M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.58M |
| December 31, 2022 | 47.68M |
| December 31, 2021 | 50.83M |
| December 31, 2020 | 45.85M |
| Date | Value |
|---|---|
| December 31, 2019 | 52.61M |
| December 31, 2018 | 67.43M |
| December 31, 2017 | 66.92M |
| December 31, 2016 | 51.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
45.85M
Minimum
2020
52.61M
Maximum
2019
49.51M
Average
50.58M
Median
2023
Revenue (Annual) Benchmarks
| Lifecore Biomedical Inc | 103.27M |
| Harrow Inc | 130.19M |
| Akebia Therapeutics Inc | 194.62M |
| Humacyte Inc | -- |
| Geron Corp | 0.237M |